Vai ai contenuti. | Spostati sulla navigazione | Spostati sulla ricerca | Vai al menu | Contatti | Accessibilità

| Crea un account

Managò, Antonella (2016) Mitochondrial potassium homeostasis and its relevance in pathophysiological contexts. [Tesi di dottorato]

Full text disponibile come:

[img]Documento PDF
Tesi non accessible fino a 01 Febbraio 2019 per motivi correlati alla proprietà intellettuale.
Visibile a: nessuno


Abstract (inglese)

During my Ph.D., my research focused on the involvement and the role of mitochondrial potassium homeostasis in the context of pathophysiological processes. I have been working on three related projects, for which the common aspect is the study of the mitochondrial potassium homeostasis and its modulation by pharmacological tools. My thesis contains a general introduction, in order to give a general up-to-date overview covering all the topics treated during my Ph.D., followed by a collection of the papers where I gave my contribution.

Concerning the first project, my studies provided new insights into the mechanism of action of an emerging pro-apoptotic, oncologically relevant molecule, namely salinomycin. This molecule was considered a valinomycin-like K+ ionophore. Its recent identification as a selective inducer of apoptosis in cancer stem cells (CSCs) and different types of non-stem cancer cells, together with the ability to spare healthy cells, led to an increased interest in unravelling its mechanism of action, poorly understood so far. Moreover, since salinomycin has been suggested to act as a K+ ionophore, it is expected to impact mitochondrial function; however detailed information on its mitochondrial effects were not available from the literature. Therefore, I explored its early effects on mitochondrial bioenergetics. In order to do this, I compared its activity with that of valinomycin (K+ ionophore) or of nigericin (K+/H+ exchanger), for which the action was already well defined by others in the past.
By using different approaches, ranging from classical bioenergetic studies on isolated mitochondria to more innovative measurement of bioenergetic parameters on intact cells, and of course by exploiting different cellular biology techniques, it has been concluded that salinomycin mediates K+/H+ exchange across the inner mitochondrial membrane, similarly to nigericin. It has been observed that salinomycin was also able to induce cell death of cells lacking some crucial actors of the apoptotic pathway (Bax/Bak-less double- knockout MEF cells). These results were compatible with the idea of direct modulation of mitochondrial function. At this point, the specificity of its action on pathologic B cells isolated from patients with chronic lymphocytic leukemia (CLL) versus B cells from healthy subjects has been investigated. The results indicated that salinomycin, when used above μM concentrations, exerts direct, mitochondrial effects, thus compromising cell survival, even in non-tumoral cells. These results were published in Managò et al., Cell Death and Disease, 2015.

Having acquired the “know-how” to assess mitochondrial bioenergetic functions, I also actively contributed to a project carried out in collaboration with Prof. Erich Gulbins from University of Essen (Germany), where I also spent five months of my Ph.D. A strict collaboration between the lab where I did my Ph.D. and the lab of Prof. Gulbins led to the discovery of a mitochondrial voltage-gated potassium channel, mtKv1.3 and to the clarification of its important role during apoptosis. Mechanistically, it has been demonstrated that the pro-apoptotic protein Bax directly interacts with and inhibits mtKv1.3, via a toxin-like mechanism. The direct inhibition of mtKv1.3 leads to hyperpolarization, mitochondrial ROS production, opening of the permeability transition pore (PTP), release of cytochrome c and finally to apoptosis. In accordance to this model, direct pharmacological inhibition of mtKv1.3 by using the membrane-permeant Kv1.3 inhibitors Psora-4, PAP-1 and clofazimine leads to cell death in different types of cancer, as demonstrated by our group.

The starting point of my second project was the fact that pyocyanin, a membrane-permeant toxin released by the Gram-negative bacterium Pseudomonas aeruginosa shows structural similarity to clofazimine, a membrane-permeant mtKv1.3 inhibitors. P. aeruginosa causes lung infections in immunocompromised patients and it is known that pyocyanin induces death of neutrophils, which plays an important role in the host’s early acute defence against pulmonary P. aeruginosa infections. However the exact mechanism of action of pyocyanin is still unknown therefore we determined whether its effect is related to Kv1.3 expression, given the crucial role of mtKv1.3 in apoptosis and the structural similarity of pyocyanin to mtKv1.3 inhibitors. First of all, it was observed by patch clamp experiments that pyocyanin is able to inhibit Kv1.3 current. At low concentration (up to 10µM), pyocyanin induced cell death preferentially in cells expressing Kv1.3. However, in the literature pyocyanin was mostly used at higher concentrations (50-100 µM), since in the sputum of patients with P. aeruginosa infections it might reach such a high concentration. Moreover, data from the literature suggested that pyocyanin might have a mitochondrial action and is able to produce high amounts of reactive oxygen species (ROS). Therefore, it has been investigated how pyocyanin impacts on mitochondrial function on a short time scale when used at high concentration (at 50µM). Again, intact cells or isolated mitochondria were used to assay the effect of this compound. It has been shown that pyocyanin determines an instantaneous production of superoxide anion at mitochondrial sites and a rapid but incomplete dissipation of the mitochondrial membrane potential. Further, it has been observed that pyocyanin can replace the function of complex III, while it does not directly alter the function of complex I. Moreover, it has been shown that ROS production induced by pyocyanin activates the acid sphyngomyelinase, shown to be present in mitochondria. This event in turn leads to the formation of ceramide, induction of apoptosis and release of cytochrome c. Genetic deficiency of acid sphyngomyelinase or scavenging of ROS induced by pyocyanin prevented cell death in neutrophils, meaning that pyocyanin, at high concentrations, induces cell death via mitochondrial reactive oxygen species and mitochondrial acid sphyngomyelinase, independently of the expression of the voltage gated potassium channel Kv1.3. These results were published in Managò et al., Antioxidant and redox signaling, 2015.

During the last period of my Ph.D, I also studied the effect of newly synthesized Psoralen derivatives and clofazimine for the treatment of cancer. Concerning the first group, they are specific inhibitors of the voltage gated potassium channel Kv1.3; the second one is a molecule already in use in clinic to treat pathologies like leprosy, which also inhibits Kv1.3 current. Due to their lipophilic structure, they are all membrane-permeant, therefore able to reach intracellular membranes, like inner mitochondrial membrane where the voltage gated potassium channel Kv1.3 is also expressed and active. As mentioned above, the specific inhibition of mtKv1.3 triggers cell death. It has previously been demonstrated that Psora-4, PAP-1 (Psoralen derivatives) and clofazimine are able to specifically induce apoptosis in cancer cells in vitro on many cancer cell lines, ex vivo on B-CLL (chronic lymphocytic leukaemia) cells obtained from patients and in vivo on melanoma tumour model. Following these promising results, in collaboration with Professor Cristina Paradisi (Department of Chemical Sciences, University of Padova), PAP-1 and clofazimine derivatives have been synthesized in order to make these molecules more soluble and mitochondriotropic (i.e.: increased tendency to target mtKv1.3).
I tested the ability of these new compounds to induce cell death in cancer cells first in vitro. Since the results obtained on different cell lines in vitro were promising and death was strictly dependent on Kv1.3 expression, it has been decided to test these compounds also in vivo on a melanoma model and on a pancreatic cancer model. During my 2-month stay at the end of the first year of my Ph.D. at the Institute for Experimental Cancer Research, University of Kiel (Germany), I performed in vivo experiments, using PAP-1 derivatives and clofazimine on SCID mouse injected with Colo357, a human pancreas tumour Kv1.3 expressing cell line, obtaining a significant reduction of the mass of the tumour (Zaccagnino, Managò et al., under submission to Oncotarget). Moreover, PAP-1 derivatives have been tested on a melanoma model in vivo, obtaining relevant results (Leanza, Romio, Becker, Azzolini, Trentin, Managò et al., manuscript in preparation, not included in the present thesis). The treatment exerted an effect on cancer, without significant side effects on healthy tissues.
Some of the most promising clofazimine-derivatives have been selected to be tested on cells deriving from acute myeloid leukaemia (AML) patient. I carried out these experiments during my stay in Germany at the Department of Molecular Biology University of Duisburg-Essen. Blood samples came directly from the haematology ward of the university-hospital in Essen. So far, we obtained preliminary results which are however controversial, since different patients were diagnosed at different stage of the disease (i.e. have different levels of pathological cells) and AML itself is a heterogeneous disease at the molecular and cytogenetic level. Therefore this work has not been included in the thesis.

Furthermore, I took part in a project of the laboratory of Prof. Holger Kalthoff (University of Kiel, Germany), concerning the study of the mechanism of action of a seaweed extract, for which I performed the experiments of bioenergetics (Geisen , Zenthoefer , Peipp , Kerber , Plenge , Managò et al., Marine drugs, 2015).
Beside the laboratory-based projects, I also contributed to the preparation of two reviews, one concerning intracellular ion channels and cancer (Leanza, Biasutto, Managò et al., Frontiers on Physiology, 2013) and the other regarding in vivo pharmacological targeting of ion channels as possible therapeutic tool against cancer (Leanza, Managò et al., BBA Mol. Cell Research, 2015).

Abstract (italiano)

Durante il mio dottorato, la mia ricerca si è concentrata sul coinvolgimento e il ruolo dell'omeostasi mitocondriale di potassio (K+) in processi fisiopatologici. Ho lavorato su tre progetti correlati, per cui l'aspetto comune è lo studio dell’omeostasi del potassio mitocondriale e la sua modulazione tramite strumenti farmacologici. La mia tesi contiene un'introduzione generale, al fine di dare una descrizione generale aggiornata di tutti gli argomenti trattati durante il mio dottorato di ricerca, seguiti da una raccolta di pubblicazioni scientifiche in cui ho dato il mio contributo.

Per quanto riguarda il primo progetto, i miei studi hanno fornito nuove informazioni sul meccanismo d'azione di una molecola pro-apoptotica emergente, rilevante dal punto di vista oncologico, nota come salinomicina. Questa molecola è stata considerata uno ionoforo di K+ simile alla valinomicina. La sua recente identificazione come induttore selettivo di apoptosi in cellule staminali tumorali (CSCs) e diversi tipi di cellule tumorali non-staminali, insieme alla sua capacità di risparmiare le cellule sane, ha portato a un interesse crescente verso la comprensione del suo meccanismo d'azione, poco noto finora. Inoltre, poiché è stato suggerito che la salinomicina agisca come uno ionoforo di K+, ci si aspetta un suo effetto sulla funzione mitocondriale. Tuttavia non erano disponibili in letteratura informazioni dettagliate sugli effetti mitocondriali di questa molecola. Pertanto, ho esplorato i suoi effetti istantanei sulla bioenergetica mitocondriale. Per fare questo, ho confrontato la sua attività con quella della valinomicina (ionoforo di K+) e della nigericina (scambiatore K+/H+), l'azione delle quali era già stata ben definita da altri in passato.
Utilizzando diversi approcci, che vanno dagli studi bioenergetici classici su mitocondri isolati alla misurazione di parametri bioenergetici con strumenti più innovativi su cellule intatte, e, naturalmente, sfruttando diverse tecniche di biologia cellulare, si è concluso che la salinomicina media lo scambio K+/H+ attraverso la membrana mitocondriale interna , analogamente alla nigericina. Inoltre, è stato visto che la salinomicina è stata in grado di indurre la morte cellulare delle cellule prive di alcuni attori cruciali del processo apoptotico (doppio knock-out di Bax/Bak in cellule MEF). Questi risultati sono compatibili con l'idea di una modulazione diretta della funzione mitocondriale da parte della salinomicina. A questo punto, è stata studiata la specificità della sua azione su cellule B patologiche isolate da pazienti con leucemia linfatica cronica (CLL) versus cellule B di soggetti sani. I risultati hanno indicato che la salinomicina, quando usata sopra concentrazioni mM, esercita effetti mitocondriali diretti, compromettendo così la sopravvivenza delle cellule, anche di quelle non tumorali. Questi risultati sono stati pubblicati in Managò et al., Cell Death and Disease, 2015.

Avendo acquisito il "know-how" per valutare le funzioni bioenergetiche mitocondriali, ho anche contribuito attivamente a un progetto realizzato in collaborazione con il Prof. Erich Gulbins dell'Università di Essen (Germania), dove ho anche trascorso cinque mesi del mio dottorato di ricerca. Una stretta collaborazione tra il laboratorio dove ho fatto il mio dottorato di ricerca e il laboratorio del Prof. Gulbins ha portato alla scoperta di un canale del potassio voltaggio-dipendente mitocondriale, mtKv1.3 e al chiarimento del suo importante ruolo durante l'apoptosi. Meccanicisticamente, è stato dimostrato che la proteina pro-apoptotica Bax interagisce direttamente con mtKv1.3 e lo inibisce, tramite un meccanismo simile a quello di alcune tossine. L'inibizione diretta di mtKv1.3 porta ad iperpolarizzazione, produzione di ROS a livello mitocondriale, apertura del poro di transizione di permeabilità (PTP), rilascio di citocromo c ed infine all'apoptosi. Secondo questo modello, l'inibizione farmacologica diretta di mtKv1.3 utilizzando inibitori di Kv1.3 permeanti la membrana come Psora-4, PAP-1 e clofazimina, porta alla morte cellulare in diversi tipi di cancro, come dimostrato dal nostro gruppo.
Il punto di partenza del mio secondo progetto è stato l’evidenza che la piocianina, una tossina permeante la membrana rilasciata dal batterio Gram-negativo Pseudomonas aeruginosa mostra somiglianza strutturale alla clofazimina, un inibitore di Kv1.3 permeante la membrana. P. aeruginosa provoca infezioni polmonari nei pazienti immunocompromessi ed è noto che la piocianina induce morte cellulare nei neutrofili, che svolgono un ruolo importante nella difesa precoce acuta dell'ospite contro infezioni polmonari da P. aeruginosa. Tuttavia l'esatto meccanismo d'azione della piocianina è ancora sconosciuta quindi abbiamo voluto studiare se il suo effetto è legato all'espressione di Kv1.3, dato il ruolo cruciale di mtKv1.3 nell’apoptosi e l'affinità strutturale della piocianina agli inibitori di Kv1.3. Prima di tutto, è stato osservato dagli esperimenti di patch-clamp che la piocianina è in grado di inibire la corrente di Kv1.3. A basse concentrazioni (fino a 10 µM), la piocianina induce morte cellulare preferenzialmente in cellule esprimenti Kv1.3. Tuttavia, in letteratura la piocianina è stata utilizzata principalmente a concentrazioni più elevate (50-100 µM), poiché nell'espettorato di pazienti con infezioni da P. aeruginosa potrebbe raggiungere tale concentrazioni. Inoltre, diversi dati in letteratura hanno suggerito che la piocianina potrebbe avere un'azione mitocondriale ed è in grado di produrre elevate quantità di specie reattive dell'ossigeno (ROS). Pertanto, è stato esaminato l'impatto della piocianina sulla funzione mitocondriale con cinetiche brevi, quando usata ad alta concentrazione (50 µM). Ancora una volta, cellule intatte o mitocondri isolati sono stati usati per saggiare l'effetto di questo composto. E 'stato osservato che la piocianina determina una produzione istantanea di anione superossido a livello di siti mitocondriali e una dissipazione rapida ma incompleta del potenziale di membrana mitocondriale. Inoltre, è stato visto che la piocianina può sostituire la funzione del complesso III, mentre non altera direttamente la funzione del complesso I. Infine, è stato dimostrato che la produzione di ROS indotta dalla piocianina attiva la sfingomielinasi acida, presente anche in mitocondri. Questo evento a sua volta porta alla formazione di ceramide, induzione di apoptosi e rilascio del citocromo c. La mancanza di espressione della sfingomielinasi acida o lo scavenging di ROS indotta dalla piocianina impedisce la morte cellulare in neutrofili, che indicando che la piocianina, ad alte concentrazioni, induce la morte cellulare attraverso specie reattive dell'ossigeno mitocondriali e sfingomielinasi acida mitocondriale, indipendentemente dall'espressione del canale del potassio voltaggio dipendente Kv1.3. Questi risultati sono stati pubblicati in Managò et al., Antioxidant and redox signaling, 2015.

Durante l'ultimo periodo del mio dottorato di ricerca, ho anche studiato l'effetto di alcuni derivati di psoraleni di nuova sintesi e della clofazimina per il trattamento del cancro. Per quanto riguarda il primo gruppo, essi sono inibitori specifici del canale del potassio voltaggio dipendente Kv1.3; la seconda è una molecola già in uso in clinica per il trattamento di patologie come la lebbra, che agisce anche come inibitore della corrente di Kv1.3. Grazie alla loro struttura lipofila, sono tutti permeanti la membrana, quindi in grado di raggiungere le membrane intracellulari, come la membrana mitocondriale interna dove il canale del potassio voltaggio dipendente Kv1.3 è espresso e attivo. Come accennato in precedenza, l'inibizione specifica di mtKv1.3 innesca la morte cellulare. È stato dimostrato che Psora-4, PAP-1 e clofazimina sono in grado di indurre specificamente apoptosi nelle cellule tumorali in vitro su molte linee cellulari tumorali, ex vivo su cellule B ottenute da pazienti con leucemia linfatica cronica e in vivo su modello di melanoma. A seguito di questi risultati promettenti, in collaborazione con la Prof. Cristina Paradisi (Dipartimento di Scienze Chimiche, Università di Padova), sono stati sintetizzati derivati del PAP-1 e della clofazimina in modo da rendere queste molecole più solubili e mitocondriotropiche (i.e.: indirizzate al mitocondrio).
Ho testato prima la capacità di questi nuovi composti di indurre morte cellulare nelle cellule tumorali in vitro. Poiché i risultati ottenuti su diverse linee cellulari sono stati promettenti e l’induzione di morte cellulare era strettamente dipendente dalla espressione Kv1.3, si è deciso di testare questi composti anche in vivo in un modello di melanoma e di tumore pancreatico. Durante il mio soggiorno di due mesi al termine del primo anno di mio dottorato presso l'Istituto per la ricerca sperimentale sul cancro, Università di Kiel (Germania), ho eseguito esperimenti in vivo, usando derivati del PAP-1 e clofazimina su topi SCID iniettati con Colo357, una linea di cellule tumorali umane di pancreas esprimenti Kv1.3, ottenendo una riduzione significativa della massa del tumore (Zaccagnino, Managò et al., under submission alla rivista Oncotarget). Inoltre, i derivati del PAP-1 sono stati testati su un modello in vivo di melanoma, dando risultati rilevanti (Leanza, Romio, Becker, Azzolini, Trentin, Managò et al., manoscritto in preparazione, non incluso nella presente tesi). Il trattamento ha esercitato un effetto sul tumore, senza rilevanti effetti collaterali sui tessuti sani.
Alcuni dei più promettenti derivati della clofazimina sono stati selezionati per essere testati su cellule derivanti da pazienti con leucemia mieloide acuta (AML). Ho eseguito questi esperimenti durante il mio soggiorno in Germania presso il Dipartimento di Biologia Molecolare dell'Università di Duisburg-Essen. I campioni di sangue provenivano direttamente dal reparto di ematologia della clinica universitaria di Essen. Finora, abbiamo ottenuto risultati preliminari che sono però controversi, poiché i pazienti sono stati diagnosticati a diversi stadi della malattia (cioè hanno livelli differenti di cellule patologiche nel sangue) e poiché la leucemia mieloide acuta è di per sé una malattia eterogenea a livello molecolare e citogenetico. Questi studi non sono stati inclusi nella tesi.

Inoltre, ho partecipato a un progetto del laboratorio del Prof. Holger Kalthoff (Università di Kiel, Germania), riguardante lo studio del meccanismo d'azione di un estratto di alghe marine, per il quale ho eseguito gli esperimenti di bioenergetica (Geisen, Zenthoefer, Peipp, Kerber, Plenge, Managò et al., Marine drugs, 2015).
Oltre ai progetti basati sull’attività in laboratorio, ho anche contribuito alla preparazione di due review, una in materia di canali ionici intracellulare in relazione al cancro (Leanza, Biasutto, Managò et al., Frontiers on Physiology, 2013) e l'altra riguardante l’utilizzo in vivo di canali ionici come bersaglio farmacologico come possibile strumento terapeutico nella cura del cancro (Leanza, Managò et al., BBA Mol Cell. Research, 2015).

Aggiungi a RefWorks
Tipo di EPrint:Tesi di dottorato
Relatore:Szabò, Ildikò
Dottorato (corsi e scuole):Ciclo 28 > Scuole 28 > BIOSCIENZE E BIOTECNOLOGIE > BIOCHIMICA E BIOFISICA
Data di deposito della tesi:30 Gennaio 2016
Anno di Pubblicazione:01 Febbraio 2016
Parole chiave (italiano / inglese):mitocondri-potassio-omeostasi/mitochondria-potassium-homeostasis
Settori scientifico-disciplinari MIUR:Area 05 - Scienze biologiche > BIO/10 Biochimica
Struttura di riferimento:Dipartimenti > Dipartimento di Biologia
Codice ID:9403
Depositato il:18 Ott 2016 17:22
Simple Metadata
Full Metadata
EndNote Format


I riferimenti della bibliografia possono essere cercati con Cerca la citazione di AIRE, copiando il titolo dell'articolo (o del libro) e la rivista (se presente) nei campi appositi di "Cerca la Citazione di AIRE".
Le url contenute in alcuni riferimenti sono raggiungibili cliccando sul link alla fine della citazione (Vai!) e tramite Google (Ricerca con Google). Il risultato dipende dalla formattazione della citazione.

Abdul, M., Santo, A., & Hoosein, N. (2003). Activity of potassium channel-blockers in breast cancer. Anticancer Research, 23(4), 3347–3351. Retrieved from\npapers3://publication/uuid/61749EAC-21CA-485A-90C7-5771962F31C3 Vai! Cerca con Google

Abdul M, Hoosein N (2002) Voltage-gated potassium ion channels in colon cancer. Oncol. Rep. 9: 961-964 Cerca con Google

Abrahams, J. P., Leslie, An. G. W., Lutter, R., & John E. Walker. (1994). © 19 9 4 Nature Publishing Group. Nature, 370, 621–628. Cerca con Google

Acin-Perez, R., & Enriquez, J. a. (2014). The function of the respiratory supercomplexes: The plasticity model. Biochimica et Biophysica Acta - Bioenergetics, 1837(4), 444–450. doi:10.1016/j.bbabio.2013.12.009 Cerca con Google

Ahmad, K. A., Iskandar, K. B., Hirpara, J. L., Clement, M. V, & Pervaiz, S. (2004). Hydrogen peroxide-mediated cytosolic acidification is a signal for mitochondrial translocation of Bax during drug-induced apoptosis of tumor cells. Cancer Res, 64(21), 7867–7878. doi:10.1158/0008-5472.CAN-04-0648 Cerca con Google

Alizadeh, A. A., Eisen, M. B., Davis, R. E., Ma, C., Lossos, I. S., Rosenwald, A., … Staudt, L. M. (2000). Distinct types of diffuse large B-cell lymphoma identi ® ed by gene expression pro ® ling, 403(February). Cerca con Google

Alnemri, E. S., Livingston, D. J., Nicholson, D. W., Salvesen, G., Thornberry, N. A., Wong, W. W., & Yuan, J. (1996). Human ICE/CED-3 Protease Nomenclature. Cell, 87(2), 171. doi:10.1016/S0092-8674(00)81334-3 Cerca con Google

Andersen, O. S. (2008). Perspectives on how to drug an ion channel. The Journal of General Physiology, 131(5), 395–7. doi:10.1085/jgp.200810012 Cerca con Google

Andersson, B., Janson, V., Behnam-Motlagh, P., Henriksson, R., & Grankvist, K. (2006). Induction of apoptosis by intracellular potassium ion depletion: Using the fluorescent dye PBFI in a 96-well plate method in cultured lung cancer cells. Toxicology in Vitro, 20(6), 986–994. doi:10.1016/j.tiv.2005.12.013 Cerca con Google

Annis, M. G., Soucie, E. L., Dlugosz, P. J., Cruz-Aguado, J. a, Penn, L. Z., Leber, B., & Andrews, D. W. (2005). Bax forms multispanning monomers that oligomerize to permeabilize membranes during apoptosis. The EMBO Journal, 24(12), 2096–2103. doi:10.1038/sj.emboj.7600675 Cerca con Google

Arafat, K., Iratni, R., Takahashi, T., Parekh, K., Al Dhaheri, Y., Adrian, T. E., & Attoub, S. (2013). Inhibitory Effects of Salinomycin on Cell Survival, Colony Growth, Migration, and Invasion of Human Non-Small Cell Lung Cancer A549 and LNM35: Involvement of NAG-1. PloS One, 8(6), e66931. doi:10.1371/journal.pone.0066931 Cerca con Google

Arcangeli, a, Crociani, O., Lastraioli, E., Masi, A., Pillozzi, S., & Becchetti, A. (2009). Targeting ion channels in cancer: a novel frontier in antineoplastic therapy. Current Medicinal Chemistry, 16(1), 66–93. doi:10.2174/092986709787002835 Cerca con Google

Arcangeli, A., & Becchetti, A. (2010). New trends in cancer therapy: Targeting ion channels and transporters. Pharmaceuticals, 3(2), 1202–1224. doi:10.3390/ph3041202 Cerca con Google

Arcangeli, A., & Becchetti, A. (2015). Novel perspectives in cancer therapy: Targeting ion channels. Drug Resistance Updates, 21-22(4), 11–19. doi:10.1016/j.drup.2015.06.002 Cerca con Google

Arsenijevic, D., Onuma, H., Pecqueur, C., Raimbault, S., Manning, B. S., Miroux, B., … Ricquier, D. (2000). Disruption of the uncoupling protein-2 gene in mice reveals a role in immunity and reactive oxygen species production. Nature Genetics, 26(4), 435–439. doi:10.1038/82565 Cerca con Google

Artym, V. V, & Petty, H. R. (2002). Molecular proximity of Kv1.3 voltage-gated potassium channels and beta(1)-integrins on the plasma membrane of melanoma cells: effects of cell adherence and channel blockers. The Journal of General Physiology, 120(1), 29–37. doi:10.1085/jgp.20028607 Cerca con Google

Ashkenazi, A. (1998). Death Receptors: Signaling and Modulation. Science, 281(5381), 1305–1308. doi:10.1126/science.281.5381.1305 Cerca con Google

Azzone, G. F., Pozzan, T., S. Massari, M. Bragadin, & Dell’antone, P. (1977). H+/site ratio and steady state distribution of divalent cations in mitochondria. FEBS Lett. 78: 21–24. Cerca con Google

Barakat, R., Goubet, I., Manon, S., Berges, T., & Rosenfeld, E. (2014). Unsuspected pyocyanin effect in yeast under anaerobiosis. MicrobiologyOpen, 3(1), 1–14. doi:10.1002/mbo3.142 Cerca con Google

Bednarczyk, P., Kowalczyk, J. E., Beresewicz, M., Dolowy, K., Szewczyk, A., & Zablocka, B. (2010). Identification of a voltage-gated potassium channel in gerbil hippocampal mitochondria. Biochem Biophys Res Commun, 397(3), 614–620. doi:10.1016/j.bbrc.2010.06.011 Cerca con Google

Beeton, C., Wulff, H., Barbaria, J., Clot-Faybesse, O., Pennington, M., Bernard, D., … Béraud, E. (2001). Selective blockade of T lymphocyte K(+) channels ameliorates experimental autoimmune encephalomyelitis, a model for multiple sclerosis. Proceedings of the National Academy of Sciences of the United States of America, 98(24), 13942–13947. doi:10.1073/pnas.241497298 Cerca con Google

Bell, E. L., Klimova, T. a., Eisenbart, J., Moraes, C. T., Murphy, M. P., Budinger, G. R. S., & Chandel, N. S. (2007). The Qo site of the mitochondrial complex III is required for the transduction of hypoxic signaling via reactive oxygen species production. The Journal of Cell Biology, 177(6), 1029–1036. doi:10.1083/jcb.200609074 Cerca con Google

Bernardi, P. (1999). Mitochondrial transport of cations: channels, exchangers, and permeability transition. Physiological Reviews, 79(4), 1127–1155. Cerca con Google

Bernardi, P. (2013). The mitochondrial permeability transition pore: a mystery solved? Frontiers in Physiology, 4(May), 1–12. doi:10.3389/fphys.2013.00095 Cerca con Google

Beutner, G., Rück, A., Riede, B., & Brdiczka, D. (1998). Complexes between porin, hexokinase, mitochondrial creatine kinase and adenylate translocator display properties of the permeability transition pore. Implication for regulation of permeability transition by the kinases. Biochimica et Biophysica Acta - Biomembranes, 1368(1), 7–18. doi:10.1016/S0005-2736(97)00175-2 Cerca con Google

Bieging, K. T., Mello, S. S., & Attardi, L. D. (2014). Unravelling mechanisms of p53-mediated tumour suppression. Nature Reviews. Cancer, 14(5), 359–70. doi:10.1038/nrc3711 Cerca con Google

Boehmerle, W., Muenzfeld, H., Springer, A., Huehnchen, P., & Endres, M. (2014). Specific targeting of neurotoxic side effects and pharmacological profile of the novel cancer stem cell drug salinomycin in mice. Journal of Molecular Medicine, 92(8), 889–900. doi:10.1007/s00109-014-1155-0 Cerca con Google

Bortner, C. D., Hughes, F. M., Cidlowski, J. A., & Carolina, N. (1997). A Primary Role for K ؉ and Na ؉ Efflux in the Activation of Apoptosis *, 272(51), 32436–32442. Cerca con Google

Boyer, P. D. (1997). the Atp Synthase — a Splendid. Sites The Journal Of 20Th Century Contemporary French Studies. Cerca con Google

Brevet, M., Fucks, D., Chatelain, D., Regimbeau, J.-M., Delcenserie, R., Sevestre, H., & Ouadid-Ahidouch, H. (2009). Deregulation of 2 potassium channels in pancreas adenocarcinomas: implication of KV1.3 gene promoter methylation. Pancreas, 38(6), 649–654. doi:10.1097/MPA.0b013e3181a56ebf Cerca con Google

Brevet, M., Haren, N., Sevestre, H., Merviel, P., & Ouadid-Ahidouch, H. (2009). DNA Methylation of Kv1.3 Potassium Channel Gene Promoter is Associated with Poorly Differentiated Breast Adenocarcinoma. Cellular Physiology and Biochemistry, 24(1-2), 25–32. doi:10.1159/000227810 Cerca con Google

Broekemeier, K. M., Dempsey, M. E., & Pfeiffer, D. R. (1989). Cyclosporin A is a potent inhibitor of the inner membrane permeability transition in liver mitochondria. The Journal of Biological Chemistry, 264(14), 7826–7830. Cerca con Google

Brierley, G.P., Baysal, K., Jung, D.W., (1994). Cation transport systems in mitochon- dria: Na+ and K+ uniports and exchangers. J. Bioenerg. Biomembr. 26 519–526. Cerca con Google

Cain, K., Brown, D. G., Langlais, C., & Cohen, G. M. (1999). Caspase activation involves the formation of the aposome, a large (approximately 700 kDa) caspase-activating complex. The Journal of Biological Chemistry, 274(32), 22686–92. doi:10.1074/jbc.274.32.22686 Cerca con Google

Caldas, C., Hahn, S. A., da Costa, L. T., Redston, M. S., Schutte, M., Seymour, A. B., … Kern, S. E. (1994). Frequent somatic mutations and homozygous deletions of the p16 (MTS1) gene in pancreatic adenocarcinoma. Nature Genetics, 8(1), 27–32. doi:10.1038/ng0994-27 Cerca con Google

Caldwell, C. C., Chen, Y., Goetzmann, H. S., Hao, Y., Borchers, M. T., Hassett, D. J., … Lau, G. W. (2009). Pseudomonas aeruginosa Exotoxin Pyocyanin Causes Cystic Fibrosis Airway Pathogenesis. The American Journal of Pathology, 175(6), 2473–2488. doi:10.2353/ajpath.2009.090166 Cerca con Google

Carroll, J., Fearnley, I. M., Skehel, J. M., Shannon, R. J., Hirst, J., & Walker, J. E. (2006). Bovine complex I is a complex of 45 different subunits. Journal of Biological Chemistry, 281(43), 32724–32727. doi:10.1074/jbc.M607135200 Cerca con Google

Cecchini, G., Schröder, I., Gunsalus, R. P., & Maklashina, E. (2002). Succinate dehydrogenase and fumarate reductase from Escherichia coli. Biochimica et Biophysica Acta, 1553(1-2), 140–157. doi:S0005272801002389 [pii] Cerca con Google

Chance, B., Sies, H., & Boveris, a. (1979). Hydroperoxide metabolism in mammalian organs. Physiological Reviews, 59(3), 527–605. Cerca con Google

Chandy, K. G., Wulff, H., Beeton, C., Pennington, M., George, a, & Cahalan, M. D. (2009). NIH Public Access, 25(5), 280–289. doi:10.1016/ Cerca con Google

Chaudhri, G., Clark, I. a., Hunt, N. H., Cowden, W. B., & Ceredig, R. (1986). Effect of antioxidants on primary alloantigen-induced T cell activation and proliferation. Journal of Immunology (Baltimore, Md. : 1950), 137(8), 2646–2652. Cerca con Google

Chen, C., & Dickman, M. B. (2005). Proline suppresses apoptosis in the fungal pathogen Colletotrichum trifolii. Proceedings of the National Academy of Sciences of the United States of America, 102, 3459–3464. doi:10.1073/pnas.0407960102 Cerca con Google

Choe, S. (2002). Ion channel structurepotassium channel structures. Nature Reviews Neuroscience, 3(2), 115–121. doi:10.1038/nrn727 Cerca con Google

Choe, S., Cushman, S., Baker, KA., Pfaffinger, P., Excitability is mediated by the T1 domain of the voltage-gated potassium channel (2002). Novartis Found Symp.;245:169–75; discussion 175–7, 261–4. Cerca con Google

Coleman, S. K., Newcombe, J., Pryke, J., & Dolly, J. O. (1999). Subunit composition of Kv1 channels in human CNS. Journal of Neurochemistry, 73(2), 849–58. doi:10.1046/j.1471-4159.1999.0730849.x Cerca con Google

Cory, S., & Adams, J. M. (2002). The Bcl2 family: regulators of the cellular life-or-death switch. Nature Reviews. Cancer, 2(9), 647–656. doi:10.1038/nrc883 Cerca con Google

Crompton, M., Virji, S., & Ward, J. M. (1998). Cyclophilin-D binds strongly to complexes of the voltage-dependent anion channel and the adenine nucleotide translocase to form the permeability transition pore. European Journal of Biochemistry / FEBS, 258(2), 729–735. doi:10.1046/j.1432-1327.1998.2580729.x Cerca con Google

Davies, K. J. (1987). Protein damage and degradation by oxygen radicals. I. general aspects. The Journal of Biological Chemistry, 262(20), 9895–9901. Retrieved from Vai! Cerca con Google

DeCoursey, T.E., Chandy, KG., Gupta, S., Cahalan, MD. (1984) Voltage-gated K+ channels in human T lymphocytes: a role in mitogenesis? Nature 307(5950):465-8 Cerca con Google

Dilisa, F., & Bernardi, P. (2006). Mitochondria and ischemia–reperfusion injury of the heart: Fixing a hole. Cardiovascular Research, 70(2), 191–199. doi:10.1016/j.cardiores.2006.01.016 Cerca con Google

Doyle, D. a. (1998). The Structure of the Potassium Channel: Molecular Basis of K+ Conduction and Selectivity. Science, 280(5360), 69–77. doi:10.1126/science.280.5360.69 Cerca con Google

Dröge, W. (2002). Free radicals in the physiological control of cell function. Physiological Reviews, 82(1), 47–95. doi:10.1152/physrev.00018.2001 Cerca con Google

Dunkley, M. L., Clancy, R. L., Cripps, A. W., & Medicine, F. (1994). Pseudomonas aeruginosa from the lung, 362–369. Cerca con Google

Folander K, Douglass J, Swanson R. (1994). Confirmation of the assignment of the gene encoding Kv1.3, a voltage-gated potassium channel (KCNA3) to the proximal short arm of human chromosome 1. Genomics.;23(1):295–6. doi:10.1006/geno.1994.1500. Cerca con Google

FitzGerald, M. G., Harkin, D. P., Silva-Arrieta, S., MacDonald, D. J., Lucchina, L. C., Unsal, H., … Haber, D. a. (1996). Prevalence of germ-line mutations in p16, p19ARF, and CDK4 in familial melanoma: analysis of a clinic-based population. Proceedings of the National Academy of Sciences of the United States of America, 93(16), 8541–5. doi:10.1073/pnas.93.16.8541 Cerca con Google

Fraser, S. P., & Pardo, L. A. (2008). Ion channels: functional expression and therapeutic potential in cancer. Colloquium on Ion Channels and Cancer. EMBO Reports, 9(6), 512–5. doi:10.1038/embor.2008.75 Cerca con Google

Friedman, J. R., & Nunnari, J. (2014). Mitochondrial form and function. Nature, 505(7483), 335–43. doi:10.1038/nature12985 Cerca con Google

Garlid, K. D., & Paucek, P. (2003). Mitochondrial potassium transport: the K+ cycle. Biochimica et Biophysica Acta (BBA) - Bioenergetics, 1606(1-3), 23–41. doi:10.1016/S0005-2728(03)00108-7 Cerca con Google

Garlid, K.D., (1988). Sodium/proton antiporters in the mitochondrial inner membrane Adv. Exp. Med. Biol. 232 37–46. Cerca con Google

Gazula, V., Strumbos, J., & Mei, X. (2010). Localization of Kv1. 3 channels in presynaptic terminals of brainstem auditory neurons. Journal of …, 518(16), 3205–3220. doi:10.1002/cne.22393.Localization Cerca con Google

George Chandy, K., Wulff, H., Beeton, C., Pennington, M., Gutman, G. A., & Cahalan, M. D. (2004). K+ channels as targets for specific immunomodulation. Trends in Pharmacological Sciences, 25(5), 280–289. doi:10.1016/ Cerca con Google

Giorgio, V., Bisetto, E., Soriano, M. E., Dabbeni-Sala, F., Basso, E., Petronilli, V., … Lippe, G. (2009). Cyclophilin D modulates mitochondrial F0F1-ATP synthase by interacting with the lateral stalk of the complex. The Journal of Biological Chemistry, 284(49), 33982–8. doi:10.1074/jbc.M109.020115 Cerca con Google

Giorgio, V., von Stockum, S., Antoniel, M., Fabbro, A., Fogolari, F., Forte, M., … Bernardi, P. (2013). Dimers of mitochondrial ATP synthase form the permeability transition pore. Proceedings of the National Academy of Sciences, 110(15), 5887–5892. doi:10.1073/pnas.1217823110 Cerca con Google

Grissmer, S., Nguyen, A. N., Aiyar, J., Hanson, D. C., Mather, R. J., Gutman, G. A., … George Chandy, K. (1994). Pharmacological Characterization of Five Cloned Voltage-Gated Expressed in Mammalian Cell Lines. Molecular Pharmacology, 45, 1227–1234. Cerca con Google

Grivennikova, V. G., & Vinogradov, A. D. (2006). Generation of superoxide by the mitochondrial Complex I. Biochimica et Biophysica Acta (BBA) - Bioenergetics, 1757(5-6), 553–561. doi:10.1016/j.bbabio.2006.03.013 Cerca con Google

Grossman, L. I., & Lomax, M. I. (1997). Nuclear genes for cytochrome c oxidase. Biochimica Et Biophysica Acta-Gene Structure And Expression, 1352, 174. Retrieved from <Go to ISI>://A1997XC75900010 Cerca con Google

Grunnet, M., Rasmussen, H. B., Hay-Schmidt, A., & Klaerke, D. A. (2003). The voltage-gated potassium channel subunit, Kv1.3, is expressed in epithelia. Biochimica et Biophysica Acta (BBA) - Biomembranes, 1616(1), 85–94. doi:10.1016/S0005-2736(03)00198-6 Cerca con Google

Gulbins, E., Sassi, N., Grassmè, H., Zoratti, M., & Szabò, I. (2010). Role of Kv1.3 mitochondrial potassium channel in apoptotic signalling in lymphocytes. Biochimica et Biophysica Acta (BBA) - Bioenergetics, 1797(6-7), 1251–1259. doi:10.1016/j.bbabio.2010.01.018 Cerca con Google

Gupta, P. B., Onder, T. T., Jiang, G., Tao, K., Kuperwasser, C., Weinberg, R. a., & Lander, E. S. (2009). Identification of Selective Inhibitors of Cancer Stem Cells by High-Throughput Screening. Cell, 138(4), 645–659. doi:10.1016/j.cell.2009.06.034 Cerca con Google

Gutman, G. A., Chandy, K. G., Grissmer, S., Lazdunski, M., McKinnon, D., Pardo, L. A., … Wang, X. (2005). International Union of Pharmacology. LIII. Nomenclature and molecular relationships of voltage-gated potassium channels. Pharmacological Reviews, 57(4), 473–508. doi:10.1124/pr.57.4.10 Cerca con Google

Hanahan, D., & Weinberg, R. (2000). The Hallmarks of Cancer Review University of California at San Francisco, 100, 57–70. Cerca con Google

Hanahan, D., & Weinberg, R. A. (2011). Hallmarks of cancer: the next generation. Cell, 144(5), 646–74. doi:10.1016/j.cell.2011.02.013 Cerca con Google

Hariharan, D., Saied, A., & Kocher, H. M. (2008). Analysis of mortality rates for pancreatic cancer across the world. Hpb, 10(1), 58–62. doi:10.1080/13651820701883148 Cerca con Google

Heinen, A., Aldakkak, M., Stowe, D. F., Rhodes, S. S., Riess, M. L., Varadarajan, S. G., & Camara, A. K. S. (2007). Reverse electron flow-induced ROS production is attenuated by activation of mitochondrial Ca2+-sensitive K+ channels. American Journal of Physiology. Heart and Circulatory Physiology, 293(3), H1400–7. doi:10.1152/ajpheart.00198.2007 Cerca con Google

Hengartner. (1997). Apoptosis. CED-4 is a stranger no more. Nature, 388(August), 728–729. doi:10.1038/41873 Cerca con Google

Hengartner, M. O. (2000). The biochemistry of apoptosis. Nature, 407(6805), 770–776. Cerca con Google

Herreros-Villanueva, M. (2012). Adjuvant and neoadjuvant treatment in pancreatic cancer. World Journal of Gastroenterology, 18(14), 1565. doi:10.3748/wjg.v18.i14.1565 Cerca con Google

Hidalgo, M. (2010). Pancreatic Cancer. New England Journal of Medicine, 362(17), 1605–1617. doi:10.1056/NEJMra0901557 Cerca con Google

Hirst, J., King, M. S., & Pryde, K. R. (2008). The production of reactive oxygen species by complex I. Biochemical Society Transactions, 36(5), 976–980. doi:10.1042/BST0360976 Cerca con Google

Hodis, E., Watson, I. R., Kryukov, G. V, Arold, S. T., Imielinski, M., Theurillat, J.-P., … Chin, L. (2012). A landscape of driver mutations in melanoma. Cell, 150(2), 251–63. doi:10.1016/j.cell.2012.06.024 Cerca con Google

Hofmann, G., Bernabei, P. A., Crociani, O., Cherubini, A., Guasti, L., Pillozzi, S., … Arcangeli, A. (2001). HERG K+ Channels Activation during 1Integrin-mediated Adhesion to Fibronectin Induces an Up-regulation of v 3 Integrin in the Preosteoclastic Leukemia Cell Line FLG 29.1. Journal of Biological Chemistry, 276(7), 4923–4931. doi:10.1074/jbc.M005682200 Cerca con Google

Holt, P. J., Morgan, D. J., & Sazanov, L. a. (2003). The Location of NuoL and NuoM Subunits in the Membrane Domain of the Escherichia coli Complex I. The Journal of Biological Chemistry, 278(44), 43114–43120. doi:10.1074/jbc.M308247200 Cerca con Google

Hoshi, T., Zagotta, WN., Aldrich, L.W. (1990) Biophysical and molecular mechanisms of Shaker potassium channel inactivation. Science 250(4980):533-8. Cerca con Google

Hruban, R. H., Maitra, A., Kern, S. E., & Goggins, M. (2007). Precursors to pancreatic cancer. Gastroenterology Clinics of North America, 36(4), 831–49, vi. doi:10.1016/j.gtc.2007.08.012 Cerca con Google

Huang, X., & Jan, L. Y. (2014). Targeting potassium channels in cancer. The Journal of Cell Biology, 206(2), 151–162. doi:10.1083/jcb.201404136 Cerca con Google

Huczynski, A. (2012). Salinomycin: a new cancer drug candidate. Chemical Biology & Drug Design, 79(3), 235–8. doi:10.1111/j.1747-0285.2011.01287.x Cerca con Google

Hulsmans, M., Van Dooren, E., & Holvoet, P. (2012). Mitochondrial Reactive Oxygen Species and Risk of Atherosclerosis. Current Atherosclerosis Reports, 14(3), 264–276. doi:10.1007/s11883-012-0237-0 Cerca con Google

Isacoff, E.Y, Jan, Y.N. & Jan, L.Y. (1991) Putative receptor for the cytoplasmic inactivation gate in the Shaker K+ channel. Nature 353:86-90. Cerca con Google

Jang, S. H., Kang, K.-S., Ryu, P. D., & Lee, S. Y. (2009). Kv1.3 voltage-gated K(+) channel subunit as a potential diagnostic marker and therapeutic target for breast cancer. BMB Reports, 42(8), 535–539. Cerca con Google

Jürgen, B., Szabó, I., Jekle, A., & Gulbins, E. (2002). Actinomycin D-induced apoptosis involves the potassium channel Kv1.3. Biochemical and Biophysical Research Communications, 295(2), 526–531. Cerca con Google

Kaczorowski, G. J., McManus, O. B., Priest, B. T., & Garcia, M. L. (2008). Ion channels as drug targets: the next GPCRs. The Journal of General Physiology, 131(5), 399–405. doi:10.1085/jgp.200709946 Cerca con Google

Kandoth, C., McLellan, M. D., Vandin, F., Ye, K., Niu, B., Lu, C., … Ding, L. (2013). Mutational landscape and significance across 12 major cancer types. Nature, 502(7471), 333–9. doi:10.1038/nature12634 Cerca con Google

Kerr, J. F., Wyllie, A. H., & Currie, A. R. (1972). Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. British Journal of Cancer, 26(4), 239–57. doi:10.1111/j.1365-2796.2005.01570.x Cerca con Google

Kevin II, D. a, Meujo, D. A., & Hamann, M. T. (2009). Polyether ionophores: broad-spectrum and promising biologically active molecules for the control of drug-resistant bacteria and parasites. Expert Opinion on Drug Discovery, 4, 109–146. doi:10.1517/17460440802661443 Cerca con Google

Kim, I., Rodriguez-Enriquez, S., & Lemasters, J. J. (2007). Selective degradation of mitochondria by mitophagy. Archives of Biochemistry and Biophysics, 462(2), 245–53. doi:10.1016/ Cerca con Google

Kim, J., Choi, A., Kim, Y. K., Kim, H. S., & Yoon, S. (2013). Low Amount of Salinomycin Greatly Increases Akt Activation , but Reduces Activated p70S6K Levels, 17304–17318. doi:10.3390/ijms140917304 Cerca con Google

Klose, J., Stankov, M. V., Kleine, M., Ramackers, W., Panayotova-Dimitrova, D., Jäger, M. D., … Vondran, F. W. R. (2014). Inhibition of Autophagic Flux by Salinomycin Results in Anti-Cancer Effect in Hepatocellular Carcinoma Cells. PLoS ONE, 9(5), e95970. doi:10.1371/journal.pone.0095970 Cerca con Google

Koch, R. O., Wanner, S. G., Koschak, A., Hanner, M., Schwarzer, C., Kaczorowski, G. J., … Knaus, H. G. (1997). Complex subunit assembly of neuronal voltage-gated K+ channels. Basis for high-affinity toxin interactions and pharmacology. J Biol Chem, 272(44), 27577–27581. doi:10.1074/jbc.272.44.27577 Cerca con Google

Koh, A. Y., Priebe, G. P., Ray, C., Van Rooijen, N., & Pier, G. B. (2009). Inescapable need for neutrophils as mediators of cellular innate immunity to acute Pseudomonas aeruginosa pneumonia. Infection and Immunity, 77(12), 5300–5310. doi:10.1128/IAI.00501-09 Cerca con Google

Kopp, F., Hermawan, A., Oak, P. S., Herrmann, A., Wagner, E., & Roidl, A. (2014). Salinomycin treatment reduces metastatic tumor burden by hampering cancer cell migration. Molecular Cancer, 13(1), 1–6. doi:10.1186/1476-4598-13-16 Cerca con Google

Koschak, a, Bugianesi, R. M., Mitterdorfer, J., Kaczorowski, G. J., Garcia, M. L., & Knaus, H. G. (1998). Subunit composition of brain voltage-gated potassium channels determined by hongotoxin-1, a novel peptide derived from Centruroides limbatus venom. The Journal of Biological Chemistry, 273(5), 2639–2644. doi:10.1074/jbc.273.5.2639 Cerca con Google

Ksenzenko, M., Konstantinov, A. a., Khomutov, G. B., Tikhonov, A. N., & Ruuge, E. K. (1983). Effect of electron transfer inhibitors on superoxide generation in the cytochrome bc1 site of the mitochondrial respiratory chain. FEBS Letters, 155(1), 19–24. doi:10.1016/0014-5793(83)80200-2 Cerca con Google

Kudin, A. P., Debska-vielhaber, G., & Kunz, W. S. (2005). Characterization of superoxide production sites in isolated rat brain and skeletal muscle mitochondria, 59, 163–168. doi:10.1016/j.biopha.2005.03.012 Cerca con Google

Kulawiak, B., Kudin, A. P., Szewczyk, A., & Kunz, W. S. (2008). BK channel openers inhibit ROS production of isolated rat brain mitochondria. Experimental Neurology, 212(2), 543–7. doi:10.1016/j.expneurol.2008.05.004 Cerca con Google

Kussmaul, L., & Hirst, J. (2006). The mechanism of superoxide production by NADH:ubiquinone oxidoreductase (complex I) from bovine heart mitochondria. Proceedings of the National Academy of Sciences of the United States of America, 103(20), 7607–12. doi:10.1073/pnas.0510977103 Cerca con Google

Lambert, a. J., & Brand, M. D. (2004). Inhibitors of the Quinone-binding Site Allow Rapid Superoxide Production from Mitochondrial NADH:Ubiquinone Oxidoreductase (Complex I). Journal of Biological Chemistry, 279(38), 39414–39420. doi:10.1074/jbc.M406576200 Cerca con Google

Lan, M., & Shi, Y. (2005). Expression of Delayed Rectifier Potassium Channels and Their Possible Roles in Proliferation of Human Gastric Cancer Cells ABBREVIATIONS KEY WORDS RIB, (December), 1342–1347. Cerca con Google

Lane, N., & Martin, W. (2010). The energetics of genome complexity. Nature, 467(7318), 929–934. doi:10.1038/nature09486 Cerca con Google

Lang, F., Föller, M., Lang, K. S., Lang, P. a., Ritter, M., Gulbins, E., … Huber, S. M. (2005). Ion channels in cell proliferation and apoptotic cell death. Journal of Membrane Biology, 205(3), 147–157. doi:10.1007/s00232-005-0780-5 Cerca con Google

Lang, F., Gulbins, E., Szabo, I., Lepple-Wienhues, A., Huber, S. M., Duranton, C., … Wieder, T. (2004). Cell volume and the regulation of apoptotic cell death. J Mol Recognit, 17(5), 473–480. doi:10.1002/jmr.705 Cerca con Google

Lavoie, E., Wangdi, T., & Kazmierczak, B. (2012). NIH Public Access, 13, 1133–1145. doi:10.1016/j.micinf.2011.07.011.Innate Cerca con Google

Leanza, L., Biasutto, L., Managò, A., Gulbins, E., Zoratti, M., & Szabò, I. (2013). Intracellular ion channels and cancer. Frontiers in Physiology, 4 SEP. doi:10.3389/fphys.2013.00227 Cerca con Google

Leanza, L., Henry, B., Sassi, N., Zoratti, M., Chandy, K. G., Gulbins, E., & Szabò, I. (2012). Inhibitors of mitochondrial Kv1.3 channels induce Bax/Bak-independent death of cancer cells. EMBO Molecular Medicine, 4(7), 577–593. doi:10.1002/emmm.201200235 Cerca con Google

Leanza, L., Managò, A., Zoratti, M., Gulbins, E., & Szabo, I. (2015). Pharmacological targeting of ion channels for cancer therapy: In vivo evidences. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. doi:10.1016/j.bbamcr.2015.11.032 Cerca con Google

Leanza, L., Trentin, L., Becker, K. a, Frezzato, F., Zoratti, M., Semenzato, G., … Szabo, I. (2013). Clofazimine, Psora-4 and PAP-1, inhibitors of the potassium channel Kv1.3, as a new and selective therapeutic strategy in chronic lymphocytic leukemia. Leukemia, 27(8), 1782–1785. doi:10.1038/leu.2013.56 Cerca con Google

Leanza, L., Venturini, E., Kadow, S., Carpinteiro, A., Gulbins, E., & Becker, K. A. (2015). Targeting a mitochondrial potassium channel to fight cancer. Cell Calcium, 58(1), 131–8. doi:10.1016/j.ceca.2014.09.006 Cerca con Google

Leanza, L., Zoratti, M., Gulbins, E., & Szabo, I. (2012). Induction of apoptosis in macrophages via Kv1.3 and Kv1.5 potassium channels. Curr Med Chem, 19(31), 5394–5404. doi:CMC-EPUB-20120801-11 [pii] Cerca con Google

Li, N. (2003). Mitochondrial Complex I Inhibitor Rotenone Induces Apoptosis through Enhancing Mitochondrial Reactive Oxygen Species Production. Journal of Biological Chemistry, 278(10), 8516–8525. doi:10.1074/jbc.M210432200 Cerca con Google

Liochev, S. I. (2013). Reactive oxygen species and the free radical theory of aging. Free Radical Biology and Medicine, 60, 1–4. doi:10.1016/j.freeradbiomed.2013.02.011 Cerca con Google

Liou, M.-Y., & Storz, P. (2010). Reactive oxygen species in cancer. Free Radic Res. (Vol. 44). doi:10.3109/10715761003667554.Reactive Cerca con Google

Liu, H. (2005). Redox-Dependent Transcriptional Regulation. Circulation Research, 97(10), 967–974. doi:10.1161/01.RES.0000188210.72062.10 Cerca con Google

Liu, Y., Fiskum, G., & Schubert, D. (2002). Generation of reactive oxygen species by the mitochondrial electron transport chain. J Neurochem, 80(5), 780–787. Retrieved from Vai! Cerca con Google

Lodish, H., Berk, A., Kaiser, C. A. & Krieger, M. (2006) Molecular cell biology, Sixth Edition, W.H. Freeman Cerca con Google

Lu, D., Choi, M. Y., Yu, J., Castro, J. E., Kipps, T. J., & Carson, D. A. (2011). Salinomycin inhibits Wnt signaling and selectively induces apoptosis in chronic lymphocytic leukemia cells, 108(32), 13253–13257. doi:10.1073/pnas.1110431108 Cerca con Google

Lu, W., & Li, Y. (2014). Salinomycin suppresses LRP6 expression and inhibits both Wnt/β-catenin and mTORC1 signaling in breast and prostate cancer cells. Journal of Cellular Biochemistry, 115(10), 1799–807. doi:10.1002/jcb.24850 Cerca con Google

Lu, Z., Klem, a M., & Ramu, Y. (2001). Ion conduction pore is conserved among potassium channels. Nature, 413(6858), 809–813. doi:10.1038/35101535 Cerca con Google

Malinska, D., Mirandola, S. R., & Kunz, W. S. (2010). Mitochondrial potassium channels and reactive oxygen species. FEBS Letters, 584(10), 2043–8. doi:10.1016/j.febslet.2010.01.013 Cerca con Google

Managò, A., Becker, K. A., Carpinteiro, A., Wilker, B., Soddemann, M., Seitz, A. P., … Gulbins, E. (2015). Pseudomonas aeruginosa Pyocyanin Induces Neutrophil Death via Mitochondrial Reactive Oxygen Species and Mitochondrial Acid Sphingomyelinase. Antioxidants & Redox Signaling, 150318122120006. doi:10.1089/ars.2014.5979 Cerca con Google

Managò, A., Leanza, L., Carraretto, L., Sassi, N., Grancara, S., Quintana-Cabrera, R., … Szabò, I. (2015). Early effects of the antineoplastic agent salinomycin on mitochondrial function. Cell Death and Disease, 6(10), e1930. doi:10.1038/cddis.2015.263 Cerca con Google

Matsumori, N., Morooka, A., & Murata, M. (2007). Conformation and location of membrane-bound salinomycin-sodium complex deduced from NMR in isotropic bicelles. Journal of the American Chemical Society, 129(48), 14989–14995. Cerca con Google

Massari, S., Balboni, E. & Azzone, G. F. (1972). Distribution of permeant cations in rat liver mitochondria under steady-state conditions. Biochim. Biophys. Acta 283: 16–22. Cerca con Google

Miao, S., Bao, J., Garcia, M. L., Goulet, J. L., Hong, X. J., Kaczorowski, G. J., … Rupprecht, K. M. (2003). Benzamide derivatives as blockers of Kv1.3 ion channel. Bioorganic & Medicinal Chemistry Letters, 13(6), 1161–4. doi:10.1016/S0960-894X(03)00014-3 Cerca con Google

Mitani, M., Yamanishi, T., Miyazaki, Y., & Otake, N. (1976). Salinomycin Effects on Mitochondrial Ion Translocation and Respiration, 9(4), 655–660. Cerca con Google

Mitchell, P., & Moyle, J. (1967). Chemiosmotic Hypothesis of Oxidative Phosphorylation. Nature, 213(5072), 137–139. doi:10.1038/213137a0 Cerca con Google

Mourre, C., Chernova, M. N., Martin-Eauclaire, M.-F., Bessone, R., Jacquet, G., Gola, M., … Crest, M. (1999). Distribution in rat brain of binding sites of kaliotoxin, a blocker of Kv1. 1 and Kv1. 3 α-subunits. Journal of Pharmacology and Experimental Therapeutics, 291(3), 943–952. Cerca con Google

Muller, F. L., Roberts, A. G., Bowman, M. K., & Kramer, D. M. (2003). Architecture of the Qo site of the cytochrome bc1 complex probed by superoxide production. Biochemistry, 42(21), 6493–9. doi:10.1021/bi0342160 Cerca con Google

Munoz, C., Saxena, A., Pakladok, T., Bogatikov, E., Wilmes, J., Seebohm, G., … Lang, F. (2012). Stimulation of HERG channel activity by β-catenin. PLoS ONE, 7(8), 3–7. doi:10.1371/journal.pone.0043353 Cerca con Google

Murphy, M. P. (2009). How mitochondria produce reactive oxygen species. Biochemical Journal, 417(1), 1–13. doi:10.1042/BJ20081386 Cerca con Google

Muzio, M., Stockwell, B. R., Stennicke, H. R., Salvesen, G. S., & Dixit, V. M. (1998). An induced proximity model for caspase-8 activation. Journal of Biological Chemistry, 273(5), 2926–2930. doi:10.1074/jbc.273.5.2926 Cerca con Google

Naujokat, C., & Steinhart, R. (2012). Salinomycin as a Drug for Targeting Human Cancer Stem Cells, 2012, 44–46. doi:10.1155/2012/950658 Cerca con Google

Nelson, D.L. & Cox M. M. (2002) I princìpi di Biochimica di Lehninger, Third edition, Zanichelli Cerca con Google

Nunnari, J., & Suomalainen, A. (2012). Mitochondria: In sickness and in health. Cell, 148(6), 1145–1159. doi:10.1016/j.cell.2012.02.035 Cerca con Google

O’Malley, Y. Q., Abdalla, M. Y., McCormick, M. L., Reszka, K. J., Denning, G. M., & Britigan, B. E. (2003). Subcellular localization of Pseudomonas pyocyanin cytotoxicity in human lung epithelial cells. American Journal of Physiology. Lung Cellular and Molecular Physiology, 284(2), L420–L430. doi:10.1152/ajplung.00316.2002 Cerca con Google

Ohnishi, T., & Salerno, J. C. (2005). Conformation-driven and semiquinone-gated proton-pump mechanism in the NADH-ubiquinone oxidoreductase (complex I). FEBS Letters, 579(21), 4555–4561. doi:10.1016/j.febslet.2005.06.086 Cerca con Google

Orrenius, S., Gogvadze, V., & Zhivotovsky, B. (2007). Mitochondrial Oxidative Stress: Implications for Cell Death. Annual Review of Pharmacology and Toxicology, 47(1), 143–183. doi:10.1146/annurev.pharmtox.47.120505.105122 Cerca con Google

Owusu-Ansah, E., & Banerjee, U. (2009). Reactive oxygen species prime Drosophila haematopoietic progenitors for differentiation. Nature, 461(7263), 537–41. doi:10.1038/nature08313 Cerca con Google

Ozawa, F., Friess, H., Tempia-Caliera, A., Kleeff, J., & Büchler, M. W. (2001). Growth factors and their receptors in pancreatic cancer. Teratogenesis, Carcinogenesis, and Mutagenesis, 21(1), 27–44. Retrieved from Vai! Cerca con Google

Papazian, D. M., Shao, X. M., Seoh, S. A., Mock, A. F., Huang, Y., & Wainstock, D. H. (1995). Electrostatic interactions of S4 voltage sensor in Shaker K+ channel. Neuron, 14(6), 1293–301. doi:10.1016/0896-6273(95)90276-7 Cerca con Google

Papazian, D. M., Timpe, L. C., Jan, Y. N., & Jan, L. Y. (1991). Alteration of voltage-dependence of Shaker potassium channel by mutations in the S4 sequence. Nature, 349(6307), 305–10. doi:10.1038/349305a0 Cerca con Google

Papazian, D.M., Schwarz, T.L., Tempel, B.L., Jan, Y.N., Jan, L.Y. (1987). Cloning of genomic and complementary DNA from Shaker, a putative potassium channel gene from Drosophila. Science 237, 749-753 Cerca con Google

Pardo, L. a, & Stühmer, W. (2013). The roles of K+ channels in cancer. Nature Reviews Cancer, 14(1), 39–48. doi:10.1038/nrc3635 Cerca con Google

Pardo, L. A., Del Camino, D., Sanchez, A., Alves, F., Bruggemann, A., Beckh, S., & Stuhmer, W. (1999) Oncogenic role of EAG. The EMBO Journal 20:5540-5547 Cerca con Google

Park, W. O. O. H., Kim, E. U. N. S., Kim, B. K., & Lee, Y. Y. (2003). Monensin-mediated growth inhibition in NCI-H929 myeloma cells via cell cycle arrest and apoptosis, 197–204. Cerca con Google

Paulus, E. F., Kurz, M., Matter, H., & Vértesy, L. (1998). Solid-state and solution structure of the salinomycin-sodium complex: Stabilization of different conformers for an ionophore in different environments. Journal of the American Chemical Society, 120(4), 8209–8221. doi:10.1021/ja973607x Cerca con Google

Perozo, E., Santacruz-Toloza, L., Stefani, E., Bezanilla, F., & Papazian, D. M. (1994). S4 mutations alter gating currents of Shaker K channels. Biophysical Journal, 66(2), 345–354. doi:10.1016/S0006-3495(94)80783-0 Cerca con Google

Preußat, K., Beetz, C., Schrey, M., Kraft, R., Wölfl, S., Kalff, R., & Patt, S. (2003). Expression of voltage-gated potassium channels Kv1.3 and Kv1.5 in human gliomas. Neuroscience Letters, 346, 33–36. doi:10.1016/S0304-3940(03)00562-7 Cerca con Google

Prevarskaya, N., Skryma, R., & Shuba, Y. (2010). Ion channels and the hallmarks of cancer. Trends in Molecular Medicine, 16(3), 107–21. doi:10.1016/j.molmed.2010.01.005 Cerca con Google

Quintero-Hernández, V., Jiménez-Vargas, J. M., Gurrola, G. B., Valdivia, H. H., & Possani, L. D. (2013). Scorpion venom components that affect ion-channels function. Toxicon, 76(9), 328–342. doi:10.1016/j.toxicon.2013.07.012 Cerca con Google

Rada, B., Lekstrom, K., Damian, S., Dupuy, C., & Leto, T. L. (2008). The Pseudomonas toxin pyocyanin inhibits the dual oxidase-based antimicrobial system as it imposes oxidative stress on airway epithelial cells. Journal of Immunology (Baltimore, Md. : 1950), 181(7), 4883–4893. doi:181/7/4883 [pii] Cerca con Google

Rada, B., & Leto, T. L. (2013). Pyocyanin effects on respiratory epithelium: Relevance in Pseudomonas aeruginosa airway infections. Trends in Microbiology, 21(2), 73–81. doi:10.1016/j.tim.2012.10.004 Cerca con Google

Ralph, S. J., Rodríguez-Enríquez, S., Neuzil, J., & Moreno-Sánchez, R. (2010). Bioenergetic pathways in tumor mitochondria as targets for cancer therapy and the importance of the ROS-induced apoptotic trigger. Molecular Aspects of Medicine, 31(1), 29–59. doi:10.1016/j.mam.2009.12.006 Cerca con Google

Rauer, H., Pennington, M., Cahalan, M., & Chandy, K. G. (1999). Structural conservation of the pores of calcium-activated and voltage- gated potassium channels determined by a sea anemone toxin. Journal of Biological Chemistry, 274(31), 21885–21892. doi:10.1074/jbc.274.31.21885 Cerca con Google

Reddy, J., Ghavami, S., Grabarek, J., Kratz, G., Wiechec, E., Fredriksson, B., … Marek, J. Ł. (2013). Biochimica et Biophysica Acta Salinomycin induces activation of autophagy , mitophagy and affects mitochondrial polarity : Differences between primary and cancer cells ☆, 1833, 2057–2069. doi:10.1016/j.bbamcr.2013.04.011 Cerca con Google

Ren, Y. R., Pan, F., Parvez, S., Fleig, A., Chong, C. R., Xu, J., … Liu, J. O. (2008). Clofazimine inhibits human Kv1.3 potassium channel by perturbing calcium oscillation in T lymphocytes. PLoS ONE, 3(12), e4009. doi:10.1371/journal.pone.0004009 Cerca con Google

Rizzuto, R., De Stefani, D., Raffaello, A., & Mammucari, C. (2012). Mitochondria as sensors and regulators of calcium signalling. Nature Reviews Molecular Cell Biology, 13(9), 566–578. doi:10.1038/nrm3412 Cerca con Google

Roesch, A., Fukunaga-kalabis, M., Schmidt, E. C., Susan, E., Brafford, P. A., Vultur, A., … Gimotty, P. (2011). NIH Public Access, 141(4), 583–594. doi:10.1016/j.cell.2010.04.020.A Cerca con Google

Rottenberg, H., Covian, R., & Trumpower, B. L. (2009). Membrane Potential Greatly Enhances Superoxide Generation by the Cytochrome bc1 Complex Reconstituted into Phospholipid Vesicles. Journal of Biological Chemistry, 284(29), 19203–19210. doi:10.1074/jbc.M109.017376 Cerca con Google

Sadikot, R. T., Blackwell, T. S., Christman, J. W., & Prince, A. S. (2005). Pathogen–Host Interactions in Pseudomonas aeruginosa Pneumonia. American Journal of Respiratory and Critical Care Medicine, 171(11), 1209–1223. doi:10.1164/rccm.200408-1044SO Cerca con Google

Saelens, X., Festjens, N., Walle, L. Vande, Gurp, M. van, Loo, G. van, & Vandenabeele, P. (2004). Toxic proteins released from mitochondria in cell death. Oncogene, 23(16), 2861–2874. doi:10.1038/sj.onc.1207523 Cerca con Google

Sánchez-Tilló, E., Fanlo, L., Siles, L., Montes-Moreno, S., Moros, a, Chiva-Blanch, G., … Postigo, a. (2014). The EMT activator ZEB1 promotes tumor growth and determines differential response to chemotherapy in mantle cell lymphoma. Cell Death and Differentiation, 21(2), 247–57. doi:10.1038/cdd.2013.123 Cerca con Google

Sazanov, L. a, & Hinchliffe, P. (2006). Structure of the hydrophilic domain of respiratory complex I from Thermus thermophilus. Science (New York, N.Y.), 311(5766), 1430–1436. doi:10.1126/science.1123809 Cerca con Google

Schadendorf, D., & Hauschild, A. (2014). Melanoma in 2013: Melanoma—the run of success continues. Nature Reviews Clinical Oncology, 11(2), 75–76. doi:10.1038/nrclinonc.2013.246 Cerca con Google

Schägger, H. (2002). Respiratory chain supercomplexes of mitochondria and bacteria. Biochimica et Biophysica Acta - Bioenergetics, 1555(1-3), 154–159. doi:10.1016/S0005-2728(02)00271-2 Cerca con Google

Scherz-Shouval, R., Shvets, E., Fass, E., Shorer, H., Gil, L., & Elazar, Z. (2007). Reactive oxygen species are essential for autophagy and specifically regulate the activity of Atg4. The EMBO Journal, 26(7), 1749–1760. doi:10.1038/sj.emboj.7601623 Cerca con Google

Schmitz, A., & Sankaranarayanan, A. (2005). Design of PAP-1, a selective small molecule Kv1. 3 blocker, for the suppression of effector memory T cells in autoimmune diseases. Molecular …, 68(5), 1254–1270. doi:10.1124/mol.105.015669.nally Cerca con Google

Sen, C. K., & Packer, L. (1996). Antioxidant and redox regulation of gene transcription. FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology, 10(7), 709–20. Retrieved from Vai! Cerca con Google

Sena, L. A., & Chandel, N. S. (2012). Physiological Roles of Mitochondrial Reactive Oxygen Species. Molecular Cell, 48(2), 158–167. doi:10.1016/j.molcel.2012.09.025 Cerca con Google

Seo, B. B., Marella, M., Yagi, T., & Matsuno-Yagi, A. (2006). The single subunit NADH dehydrogenase reduces generation of reactive oxygen species from complex I. FEBS Letters, 580(26), 6105–6108. doi:10.1016/j.febslet.2006.10.008 Cerca con Google

Seoh, S. A., Sigg, D., Papazian, D. M., & Bezanilla, F. (1996). Voltage-sensing residues in the S2 and S4 segments of the Shaker K+ channel. Neuron, 16(6), 1159–1167. doi:10.1016/S0896-6273(00)80142-7 Cerca con Google

Shanmughapriya, S., Rajan, S., Hoffman, N. E., Koch, W. J., Elrod, J. W., Shanmughapriya, S., … Higgins, A. M. (2015). SPG7 Is an Essential and Conserved Component of the Mitochondrial Permeability Transition Pore Article SPG7 Is an Essential and Conserved Component of the Mitochondrial Permeability Transition Pore, 1–16. Cerca con Google

Sheppard, K. E., & McArthur, G. A. (2013). The Cell-Cycle Regulator CDK4: An Emerging Therapeutic Target in Melanoma. Clinical Cancer Research, 19(19), 5320–5328. doi:10.1158/1078-0432.CCR-13-0259 Cerca con Google

Shieh, C. C., Coghlan, M., Sullivan, J. P., & Gopalakrishnan, M. (2000). Potassium channels: molecular defects, diseases, and therapeutic opportunities. Pharmacological Reviews, 52(4), 557–594. Cerca con Google

Shoudai, K., Nonaka, K., Maeda, M., Wang, Z.-M., Jeong, H.-J., Higashi, H., … Akaike, N. (2007). Effects of various K+ channel blockers on spontaneous glycine release at rat spinal neurons. Brain Research, 1157, 11–22. doi:10.1016/j.brainres.2006.09.097 Cerca con Google

Siegel, R. L., Miller, K. D., & Jemal, A. (2015). Cancer statistics, 2015. CA: A Cancer Journal for Clinicians, 65(1), 5–29. doi:10.3322/caac.21254 Cerca con Google

Smith, G. a M., Tsui, H. W., Newell, E. W., Jiang, X., Zhu, X. P., Tsui, F. W. L., & Schlichter, L. C. (2002). Functional up-regulation of HERG K+ channels in neoplastic hematopoietic cells. Journal of Biological Chemistry, 277(21), 18528–18534. doi:10.1074/jbc.M200592200 Cerca con Google

Sorgato, M. C., Keller, B. U., & Stühmer, W. (1987). Patch-clamping of the inner mitochondrial membrane reveals a voltage-dependent ion channel. Nature, 330(6147), 498–500. doi:10.1038/330498a0 Cerca con Google

Starkov, A. A., & Fiskum, G. (2001). Myxothiazol Induces H2O2 Production from Mitochondrial Respiratory Chain. Biochemical and Biophysical Research Communications, 281(3), 645–650. doi:10.1006/bbrc.2001.4409 Cerca con Google

Steinbeck, M. J., Khan, A. U., & Karnovsky, M. J. (1993). Extracellular production of singlet oxygen by stimulated macrophages quantified using 9,10-diphenylanthracene and perylene in a polystyrene film. Journal of Biological Chemistry, 268(21), 15649–15654. Cerca con Google

Szabó, I., Bock, J., Grassmé, H., Soddemann, M., Wilker, B., Lang, F., … Gulbins, E. (2008). Mitochondrial potassium channel Kv1.3 mediates Bax-induced apoptosis in lymphocytes. Proceedings of the National Academy of Sciences of the United States of America, 105(39), 14861–14866. doi:10.1073/pnas.0804236105 Cerca con Google

Szabò, I., Bock, J., Jekle, A., Soddemann, M., Adams, C., Lang, F., … Gulbins, E. (2005). A novel potassium channel in lymphocyte mitochondria. Journal of Biological Chemistry, 280(13), 12790–12798. doi:10.1074/jbc.M413548200 Cerca con Google

Szabò, I., Leanza, L., Gulbins, E., & Zoratti, M. (2012). Physiology of potassium channels in the inner membrane of mitochondria. Pflugers Archiv European Journal of Physiology, 463(2), 231–246. doi:10.1007/s00424-011-1058-7 Cerca con Google

Szabò, I., Soddemann, M., Leanza, L., Zoratti, M., & Gulbins, E. (2011). Single-point mutations of a lysine residue change function of Bax and Bcl-xL expressed in Bax- and Bak-less mouse embryonic fibroblasts: novel insights into the molecular mechanisms of Bax-induced apoptosis. Cell Death and Differentiation, 18(3), 427–438. doi:10.1038/cdd.2010.112 Cerca con Google

Szabo, I., Trentin, L., Trimarco, V., Semenzato, G., & Leanza, L. (2015). Biophysical Characterization and Expression Analysis of Kv1.3 Potassium Channel in Primary Human Leukemic B Cells. Cellular Physiology and Biochemistry, 37(3), 965–978. doi:10.1159/000430223 Cerca con Google

Szabo, I., & Zoratti, M. (2014). Mitochondrial channels: ion fluxes and more. Physiological Reviews, 94(2), 519–608. doi:10.1152/physrev.00021.2013 Cerca con Google

Tempel, B.L., Papazian, D.M., Schwarz, T.L., Jan, Y.N., Jan L.Y. (1987). Sequence of a probable potassium channel component encoded at Shaker locus of Drosophila. Science 237, 770-775 Cerca con Google

Thornberry, N. A., Rano, T. A., Peterson, E. P., Rasper, D. M., Timkey, T., Garcia-Calvo, M., … Nicholson, D. W. (1997). A combinatorial approach defines specificities of members of the caspase family and granzyme B. Functional relationships established for key mediators of apoptosis. The Journal of Biological Chemistry, 272(29), 17907–17911. Cerca con Google

Uttara, B., Singh, A. V, Zamboni, P., & Mahajan, R. T. (2009). Oxidative stress and neurodegenerative diseases: a review of upstream and downstream antioxidant therapeutic options. Current Neuropharmacology, 7, 65–74. doi:10.2174/157015909787602823 Cerca con Google

van den Heuvel, L., & Smeitink, J. (2001). The oxidative phosphorylation (OXPHOS) system: nuclear genes and human genetic diseases. BioEssays : News and Reviews in Molecular, Cellular and Developmental Biology, 23(6), 518–525. doi:10.1002/bies.1071 Cerca con Google

Vennekamp, J., Wulff, H., Beeton, C., Calabresi, P. A., Grissmer, S., Wolfram, H., & Chandy, K. G. (2004). Kv1 . 3-Blocking 5-Phenylalkoxypsoralens : A New Class of Immunomodulators, 65(6), 1364–1374. Cerca con Google

Verdoodt, B., Vogt, M., Schmitz, I., Liffers, S., Tannapfel, A., & Mirmohammadsadegh, A. (2012). Salinomycin Induces Autophagy in Colon and Breast Cancer Cells with Concomitant Generation of Reactive Oxygen Species, 7(9). doi:10.1371/journal.pone.0044132 Cerca con Google

Vicente, R., Escalada, A., Villalonga, N., Texido, L., Roura-Ferrer, M., Martín-Satué, M., … Felipe, A. (2006). Association of Kv1.5 and Kv1.3 contributes to the major voltage-dependent K+ channel in macrophages. Journal of Biological Chemistry, 281(49), 37675–37685. doi:10.1074/jbc.M605617200 Cerca con Google

Votyakova, T. V, & Reynolds, I. J. (2001). DC m -Dependent and -independent production of reactive oxygen species by rat brain mitochondria. Society, 266–277. Cerca con Google

Wajant, H. (2002). The Fas signaling pathway: more than a paradigm. Science (New York, N.Y.), 296(5573), 1635–1636. doi:10.1126/science.1071553 Cerca con Google

Wang, F., He, L., Dai, W., Xu, Y., Wu, D., Lin, C., … Xu, L. (2012). Salinomycin Inhibits Proliferation and Induces Apoptosis of Human Hepatocellular Carcinoma Cells In Vitro and In Vivo, 7(12). doi:10.1371/journal.pone.0050638 Cerca con Google

Ward, K. A., Lazovich, D., & Hordinsky, M. K. (2012). Germline melanoma susceptibility and prognostic genes: A review of the literature. Journal of the American Academy of Dermatology, 67(5), 1055–1067. doi:10.1016/j.jaad.2012.02.042 Cerca con Google

Wei, M. C., Lindsten, T., Mootha, V. K., Weiler, S., Gross, A., Ashiya, M., … Korsmeyer, S. J. (2000). tBID, a membrane-targeted death ligand, oligomerizes BAK to release cytochrome c. Genes and Development, 14(16), 2060–2071. doi:10.1101/gad.14.16.2060 Cerca con Google

Willis, S. N., Fletcher, J. I., Kaufmann, T., van Delft, M. F., Chen, L., Czabotar, P. E., … Huang, D. C. S. (2007). Apoptosis initiated when BH3 ligands engage multiple Bcl-2 homologs, not Bax or Bak. Science (New York, N.Y.), 315(5813), 856–859. doi:10.1126/science.1133289 Cerca con Google

Wilson, R., Sykes, D. a., Watson, D., Rutman, a., Taylor, G. W., & Cole, P. J. (1988). Measurement of Pseudomonas aeruginosa phenazine pigments in sputum and assessment of their contribution to sputum sol toxicity for respiratory epithelium. Infection and Immunity, 56(9), 2515–2517. Cerca con Google

Witkiewicz, A. K., McMillan, E. A., Balaji, U., Baek, G., Lin, W.-C., Mansour, J., … Knudsen, E. S. (2015). Whole-exome sequencing of pancreatic cancer defines genetic diversity and therapeutic targets. Nature Communications, 6, 6744. doi:10.1038/ncomms7744 Cerca con Google

Xia, D., Yu, C. a, Kim, H., Xia, J. Z., Kachurin, a M., Zhang, L., … Deisenhofer, J. (1997). Crystal structure of the cytochrome bc1 complex from bovine heart mitochondria. Science (New York, N.Y.), 277(5322), 60–66. doi:10.1126/science.277.5322.60 Cerca con Google

Xu, J., Koni, P. a., Wang, P., Li, G., Kaczmarek, L., Wu, Y., … Desir, G. V. (2003). The voltage-gated potassium channel Kv1.3 regulates energy homeostasis and body weight. Human Molecular Genetics, 12(5), 551–559. doi:10.1093/hmg/ddg049 Cerca con Google

Yamada, K., Hara, N., Shibata, T., Osago, H., & Tsuchiya, M. (2006). The simultaneous measurement of nicotinamide adenine dinucleotide and related compounds by liquid chromatography/electrospray ionization tandem mass spectrometry. Analytical Biochemistry, 352(2), 282–285. doi:10.1016/j.ab.2006.02.017 Cerca con Google

Yao, X., Chang, A. Y., Boulpaep, E. L., Segal, A. S., & Desir, G. V. (1996). Molecular cloning of a glibenclamide-sensitive, voltage-gated potassium channel expressed in rabbit kidney. The Journal of Clinical Investigation, 97(11), 2525–33. doi:10.1172/JCI118700 Cerca con Google

Yellen, G. (2002). channels and their relatives, 419(September). Cerca con Google

Youle, R. J., & Strasser, A. (2008). The BCL-2 protein family: opposing activities that mediate cell death. Nature Reviews. Molecular Cell Biology, 9(1), 47–59. doi:10.1038/nrm2308 Cerca con Google

Yu, S. P., & Choi, D. W. (2000). Ions , cell volume , and apoptosis, 97(17), 9360–9362. Cerca con Google

Yu, S. P., & Kerchner, G. a. (1998). Rapid Communication Endogenous Voltage-Gated Potassium Channels in Human Embryonic Kidney ( HEK293 ) Cells. Journal of Neuroscience Research, 617(January), 612–617. Retrieved from;cmd=Retrieve&amp;dopt=AbstractPlus&amp;list_uids=9632317 Vai! Cerca con Google

Zamzami, N., & Kroemer, G. (2001). The mitochondrion in apoptosis: how Pandora’s box opens. Nature Reviews. Molecular Cell Biology, 2(1), 67–71. doi:10.1038/35048073 Cerca con Google

Zhou, J., Li, P., Xue, X., He, S., Kuang, Y., Zhao, H., … Guo, X. (2013). Salinomycin induces apoptosis in cisplatin-resistant colorectal cancer cells by accumulation of reactive oxygen species. Toxicology Letters, 222(2), 139–145. doi:10.1016/j.toxlet.2013.07.022 Cerca con Google

Zhu, L., Zhen, Y., Zhang, Y., Guo, Z., Dai, J., & Wang, X. (2013). Salinomycin Activates AMP-Activated Protein Kinase- Dependent Autophagy in Cultured Osteoblastoma Cells : A Negative Regulator against Cell Apoptosis, 8(12), 1–11. doi:10.1371/journal.pone.0084175 Cerca con Google

Zoratti, M., De Marchi, U., Gulbins, E., & Szabò, I. (2009). Novel channels of the inner mitochondrial membrane. Biochimica et Biophysica Acta (BBA) - Bioenergetics, 1787(5), 351–363. doi:10.1016/j.bbabio.2008.11.015 Cerca con Google

Zoratti, M., & Szabó, I. (1994). Electrophysiology of the inner mitochondrial membrane. Journal of Bioenergetics and Biomembranes, 26(5), 543–553. doi:10.1007/BF00762739 Cerca con Google

Zorov, D. B., Juhaszova, M., & Sollott, S. J. (2014). Mitochondrial Reactive Oxygen Species (ROS) and ROS-Induced ROS Release. Physiological Reviews, 94(3), 909–950. doi:10.1152/physrev.00026.2013 Cerca con Google

Solo per lo Staff dell Archivio: Modifica questo record